Symmetry Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-2,537
Closed -$461K – 669
2021
Q1
$461K Sell
2,537
-15
-0.6% -$3.48K 0.03% 428
2020
Q4
$510K Buy
2,552
+432
+20% +$87.8K 0.04% 368
2020
Q3
$465K Buy
+2,120
New +$449K 0.04% 354

Other funds holding TDOC

Symmetry Partners's TDOC Position: Q2 2021 in Review

Symmetry Partners sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 2,537 shares — an estimated $461K sold.

Symmetry Partners first reported a position in TDOC in Q3 2020 and held it in 3 quarters. The position peaked at $510K in Q4 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Symmetry Partners reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Symmetry Partners sold 2,537 Teladoc Health shares in Q2 2021, an estimated $461K.
  • Symmetry Partners first reported a position in Teladoc Health in Q3 2020 and held it in 3 quarters.
  • Symmetry Partners's Teladoc Health position peaked at $510K in Q4 2020.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Symmetry Partners's 13F filing for Q2 2021, filed 7 Jul 2021.